Quanergy Accelerates a Safe Return to Work with 3D LiDAR Solutions for Social Distancing
Quanergy Systems, Inc., a leading provider of LiDAR (Light Detection and Ranging) sensors and smart perception solutions, today announced the expansion of its Flow Management™ Platform to support solutions that enforce social distancing, regarded by medical experts as the most impactful strategy to halt the spread of COVID-19. These solutions will assist businesses and public entities around the world in returning to work while keeping people safe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200428005957/en/
3D LiDAR Social Distancing Solutions to Accelerate Safe Return to Work (Photo: Business Wire)
Quanergy’s Flow Management Platform, which combines its state-of-the-art 3D LiDAR sensors with its AI-powered QORTEX™ Perception Software, enables the development of sophisticated social distancing solutions to anonymously and accurately track and analyze the flow of people in real time within retail locations, airports, public venues, commercial and government buildings, and industrial warehouses.
LiDAR uses light to locate and identify objects with a high degree of accuracy in any lighting conditions. Quanergy’s QORTEX Perception Software uses LiDAR data to identify and track individuals throughout an environment without compromising or storing any personal privacy information, unlike camera-based systems. It also does not require user opt-in or the sharing of personal data, thus providing a far more effective social distancing solution than alternatives.
In response to the COVID-19 pandemic and social distancing directives, Quanergy is working with partners to deploy its Flow Management Platform which accurately measures the location of and distance between people, as well as the number of people in a given location to prevent overcrowding. When the distance between individuals is less than the allowed social distance, or the number of people in an area exceeds a given limit, an alert is issued and personnel may be dispatched. When combined with technology such as thermal cameras, the platform identifies individuals with high-body temperatures, helping curb the spread of the virus. Quanergy’s Flow Management™ Platform also accurately counts people entering and exiting common areas, such as conference rooms, to maintain the desired density of people.
“In order for communities and cities to re-open and for the public to feel safe re-entering society, there must be a way to responsibly enforce social distancing,” said Dr. Kevin J. Kennedy, Chairman and CEO of Quanergy. “We believe LiDAR can play a key role in accelerating our return to work and restarting our economy. Quanergy is working closely with our current and new global partners to deploy solutions to instill confidence for businesses and the public in returning to our lives outside our homes.”
The following examples demonstrate the power of Quanergy’s Flow Management™ Platform as a critical tool to enforce social distancing:
- Businesses –Control the maximum number of people in common areas such as conference rooms and break rooms, and maintain social distancing.
- Distribution centers –Guarantee goods delivery while protecting the safety of employees.
- Factories – Restart production by ensuring all employees are not exhibiting signs of the virus before entering facilities, including conducting employee temperature checks.
- Train, Metro stations – Avoid long-queues by replacing turnstiles with contact-less solutions that can accurately keep count of the number of people entering and exiting a station.
- Buses, trains – Ensure safety on public transit during high-traffic commute hours by tracking and reporting maximum people count.
- Retail, airports, public offices – Reduce wait-time in security lines and automatically dispatch cleaning services to specific areas.
Social distancing solutions built upon Quanergy’s Flow Management Platform, will soon be available around the world through Quanergy’s company partners. For instance:
- Quantum Labs, based in Australia, has deployed solutions for high profile, globally recognized sites, airports, intersections and high security facilities that are ideal at providing not only social distance monitoring, but also provide significant enhancements to the ongoing security of the site.
- iCENT, a leading 3D LiDAR-based security and safety platform solution provider in Korea, provides monitoring services through its iSaver technology to predict and prevent human and property damage from safety and security threats at urban and industrial sites and special facilities.
- CRON Systems, an India-based 3D LiDAR solutions provider, integrates data from thermal temperature cameras allowing accurate tracking of individuals in a zone and highlighting threat levels.
- Axone, a French integrated security solution provider, is preparing an offer combining different technologies for people management, including temperature detection with thermal cameras, people counting, people tracking, crowd detection, and analytics.
- iinside, a US based airport motion analytics company, recently released SafeDistance, to monitor and analyzes crowd density in public spaces, such as airports.
"Quanergy delivers the best LiDAR platform for generating the iinside motion analytics used by some of the best and largest US airports to manage passenger congestion. Faced with new social distancing guidelines, this same technology is now being applied to enhance passenger safety," said Sam Kamel, President and CEO of iinside.
As part of our commitment to facilitate a safe return to the work place, Quanergy is offering a complimentary loaner/license program to qualified partners and end users.
To request more information about Quanergy’s Flow Management Platform and use for social distancing applications, please contact our sales team.
About Quanergy Systems, Inc.
Quanergy Systems, Inc. was founded in 2012 and builds on decades of experience of its team in the areas of optics, photonics, optoelectronics, artificial intelligence software, and control systems. Headquartered in Sunnyvale, California, in the heart of Silicon Valley, Quanergy offers a high-performance AI-powered LiDAR platform designed to accelerate the automation of key business processes to increase productivity, efficiency, and safety of our 3D world. By providing actionable insights to organizations across major industries including, mapping, security, smart cities, and smart spaces, industrial automation and transportation, Quanergy is enabling its partners and their end-users to deploy innovative solutions to drive their business growth and ultimately, improve the quality of life for people around the world. For more information, visit www.quanergy.com.
Marketing Communications Manager
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
bitFlyer Europe and Quazard Partner to Bring First Ever Trading Competition to Botwars Ultimate Trading1.6.2020 06:00:00 CEST | Press release
Leading cryptocurrency exchange bitFlyer, is partnering with crypto-trading game developer Quazard, to bring the first ever gamified trading competition to the Botwars Ultimate Trading universe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200531005005/en/ bitFlyer and Quazard bring the first gamified trading competition to the Botwars Ultimate Trading universe (Graphic: Business Wire) The competition, which launches today, allows Botwars players to compete in a free to enter crypto-trading simulator to win real Bitcoin. This is the first trading competition to launch on Botwars, and the only live trading competition of its type. In Botwars Ultimate Trading, players need to build an army of trading robots (each representing a trade) and lead them into battle to conquer the cryptocurrency markets. Botwars is a real-time, gamified currency trading experience where you will learn new trading skills, unlock powerful new tradin
Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment, Showing Improvement in Recovery Time1.6.2020 03:00:00 CEST | Press release
Celltrion Group today announced positive pre-clinical results for its COVID-19 antiviral antibody treatment, with data demonstrating a 100-fold reduction in the viral load of SARS-CoV-2, the virus causing COVID-19. The treatment was also able to show improvement in lung lesions to a normal activity level in animal models. The pre-clinical study was conducted in an animal model in collaboration with one of the Korean National Universities, Chungbuk National University College of Medicine. The trial set out to assess the efficacy of two dosage amounts (low and high) for the antiviral antibody treatment. In comparison to the placebo-controlled group, the research team observed improved recovery in terms of clinical symptom scores such as runny nose, cough and body aches, after the first day of treatment. From the fifth day, significant clinical remission was observed. Reverse transcriptase polymerase chain reaction (RT-PCR) measurement and cell culture-based viral diagnosis were used to a
Idriverplus Joins the “Automate with Velodyne” Ecosystem29.5.2020 20:31:00 CEST | Press release
Velodyne Lidar, Inc. and Idriverplus today announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. Through the program, Velodyne will further collaborate with Idriverplus to support its continued innovation and promote Idriverplus autonomous vehicles, including street cleaners, passenger cars and logistics vehicles. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200529005589/en/ Velodyne Lidar, Inc. and Idriverplus announced an expanded partnership and Idriverplus inclusion into the Automated with Velodyne integrator ecosystem, which helps companies grow their businesses while using Velodyne lidar technology. (Photo: Velodyne Lidar) Recently, Velodyne signed a multi-year sales agreement with Idriverplus to provide Puck™ sensors for the mass production of autonomous vehicles. Idriverplu
Interim Data from the Open Label Phase 2 OPTIC Study of Iclusig ® (ponatinib) for Chronic Phase-CML Presented at the ASCO and EHA Virtual Meetings29.5.2020 14:00:00 CEST | Press release
Incyte (Nasdaq:INCY) today announced that data from the interim analysis of the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial, which was sponsored by Takeda and co-funded by Incyte, will be presented during an oral session at the upcoming 2020 American Society of Clinical Oncology Virtual Meeting (ASCO20; May 29 – May 31) (Abstract #7502)1; and at the virtual 25th Congress of the European Hematology Association (EHA25; June 11 – 14) (Abstract #S172)2. The OPTIC trial is an ongoing randomized, open-label study prospectively evaluating response-based dosing regimens of Iclusig® (ponatinib) over a range of three starting doses (45 mg, 30 mg, 15 mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML), who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow up of approximately 21 months, data from the interim analysis of the OPTIC trial show that the optimal benefit-r
Takeda to Present Data from the ICLUSIG ® (ponatinib) Clinical Trial Program that Could Prove Practice-Changing for the Treatment of Chronic-Phase CML29.5.2020 14:00:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that interim analysis data from the Phase 2 OPTIC (Optimizing Ponatinib Treatment In CML) trial will be presented during an oral session at the virtual 56thAmerican Society of Clinical Oncology (ASCO) Annual Meeting and the 25thEuropean Hematology Association (EHA) Annual Meeting. The OPTIC trial is an ongoing, randomized, open-label study prospectively evaluating response-based dosing regimens of ICLUSIG® (ponatinib) over a range of three starting doses (45-, 30-, or 15-mg) with the aim of optimizing its efficacy and safety in patients with chronic-phase chronic myeloid leukemia (CP-CML) who are resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. With a median follow-up of approximately 21 months, data from the interim analysis of OPTIC show that the optimal benefit-risk profile for ICLUSIG in patients with CP-CML is achieved with a daily starting dose of 45-mg and, upon achieving ≤1% BCR-A
Takeda Receives Positive CHMP Opinion for Pre-Filled Syringe Presentation of TAKHZYRO ® (lanadelumab) for Use as a Preventive Treatment for Hereditary Angioedema Attacks29.5.2020 14:00:00 CEST | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion on a Type II Variation regulatory application and recommended the approval of a pre-filled syringe presentation of TAKHZYRO® (lanadelumab). TAKHZYRO is a subcutaneous injectable prescription medication approved in Europe for routine prevention of recurrent attacks of hereditary angioedema (HAE) in patients aged 12 years and older. HAE is a rare genetic disorder that results in recurrent attacks of oedema – swelling – in various parts of the body, including the abdomen, face, feet, genitals, hands and throat.1,2,3 “Our goal is to continuously innovate in all areas of HAE management,” said Isabel Kalofonos, Global Product Strategy Lead, HAE, Takeda. “This positive opinion marks another important step forward as we aim to enhance the experience of treatment administration for peo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom